Amp Capital Investors LTD Dexcom Inc Transaction History

Amp Capital Investors LTD

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$129.87 - $162.82 $3.87 Million - $4.86 Million	-29,833 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $717,838 - $963,171	-6,727 Reduced 18.4%	29,833 $16.3 Million
Q2 2021 Aug 16, 2021	SELL	$80.99 - $107.93 $534,776 - $712,661	-6,603 Reduced 15.3%	36,560 $15.6 Million
Q1 2021 May 17, 2021	SELL	$84.79 - $104.74 $238,514 - $294,633	-2,813 Reduced 6.12%	43,163 $15.5 Million
Q4 2020 Feb 12, 2021	SELL	$78.0 - $104.5 $676,026 - $905,701	-8,667 Reduced 15.86%	45,976 $16.7 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $606,106 - $716,780	6,346 Added 13.14%	54,643 $22 Million
Q2 2020 Aug 14, 2020	BUY	$62.68 - $105.34 $111,570 - $187,505	1,780 Added 3.83%	48,297 $19.2 Million
Q1 2020 May 13, 2020	BUY	$47.79 - $75.63 $929,467 - $1.47 Million	19,449 Added 71.85%	46,517 $12.9 Million
Q4 2019 Feb 13, 2020	SELL	$36.62 - $57.29 $79,135 - $123,803	-2,161 Reduced 7.39%	27,068 $5.85 Million
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $1.06 Million - $1.31 Million	-29,848 Reduced 50.52%	29,229 $4.34 Million
Q2 2019 Aug 14, 2019	SELL	$27.84 - $38.92 $283,439 - $396,244	-10,181 Reduced 14.7%	59,077 $8.61 Million
Q1 2019 May 15, 2019	BUY	$28.07 - $38.18 $1.21 Million - $1.65 Million	43,151 Added 165.29%	69,258 $8.2 Million
Q4 2018 Feb 13, 2019	BUY	$26.99 - $37.37 $704,627 - $975,618	26,107 New	26,107 $3.09 Million
Q4 2017 Feb 14, 2018	SELL	$11.12 - $15.38 $225,824 - $312,337	-20,308 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	20,308	20,308 $1.49 Million

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.